Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDARUCIZUMAB vs IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDARUCIZUMAB vs IMDEVIMAB: Safety Overview

Metric IDARUCIZUMAB IMDEVIMAB
Total FAERS Reports 1,562 432
Deaths Reported 1,014 24
Death Rate 64.9% 5.6%
Hospitalizations 570 202
Average Patient Age 77.6 yrs 56.2 yrs
% Female Patients 42.7% 52.7%
Manufacturer Boehringer Ingelheim Pharmaceuticals,... N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A